Tune into X Spaces this Thursday, March 14, 2024, at 4 PM UTC for an insightful discussion about Rejuve.Bio and AI-driven longevity and aging-related disease treatments using, featuring our CEO Dr. Ben Goertzel, and Rejuve.Bio's CEO Kennedy Schaal and Chief Biotechnology Officer Dr. Axel Schumacher.
? Set a reminder now at https://x.com/i/spaces/1mnxepWLRWnJX
